ACTIV-H

It's the day @CPHI Milan ! Great innovations and technologies for the future of pharma. Let's connect to talk about how our technologie Can help reach a New chemical diversity with ACTIV-H. Feel free to get in touch here : contact@activ-h.com #pharma #innovation #smallmolecules #APIs

ACTIV-H rejoint la dynamique communauté de France Chimie Nouvelle-Aquitaine ! 🎉   Nous sommes ravis et honorés de faire désormais partie de la communauté qui façonne l’avenir de l’industrie chimique en région. Un immense merci à France Chimie Nouvelle-Aquitaine pour l’accueil chaleureux et le superbe post de bienvenue. 🙏   Chez ACTIV-H, nous sommes impatients de collaborer avec les acteurs clés de la chimie régionale, de partager nos expertises et d’apporter notre contribution aux nombreuses initiatives. Ensemble, nous relèverons les défis de demain et ouvrirons de nouvelles perspectives pour notre secteur en Région Nouvelle-Aquitaine ! 💡   A très bientôt aux prochains événements et projets !   Notre activité ⚗ Chez ACTIV-H, nous sommes spécialisés dans la synthèse de nouvelles molécules et dans l'enrichissement de la diversité chimique pour nos clients. Nos services et technologies de pointe, basés sur la chimie des (super)acides et les technologies de flux avancées, ouvrent la voie à une diversité moléculaire sans précédent. Une stratégie qui ouvre des perspectives concrètes pour le secteur de la découverte de médicaments en explorant des espaces chimiques nouveaux. En réalisant des transformations directes et sélectives souvent inaccessibles par les méthodes traditionnelles, nous offrons une alternative nouvelle pour relever les défis liés au développement de nouveaux traitements. Offrir de nouvelles alternatives au service de la santé est essentiel, et notre offre de diversification chimique représente une nouvelle option sur le marché.   Les avantages de nos solutions 🚀 ▶ Accès à des molécules uniques avec une boîte à outils complémentaire ▶ Accès à de nouveaux espaces chimiques et de propriété intellectuelle ▶ Un mode d'activation moléculaire unique ciblant des positions inertes ou métaboliquement sensibles ▶ Revitalisation des molécules existantes en libérant de nouvelles possibilités dans la découverte de médicaments ▶ Un large portefeuille de transformations   Collaborons 🤝 ! N'hésitez pas à nous contacter ici 📧 contact@activ-h.com pour en savoir plus sur notre technologie ! 🌐 www.activ-h.com #FranceChimie #NouvelleAquitaine #Chimie #Innovation #Collaboration #Industrie #Réseau  

Join us at #CPHIMilan 2024 ! 📅 8th - 10th October 📍 Fiera Milano – Italy ! At ACTIV-H, we specialize in delivering novel molecules and enhancing the chemical diversity for our clients. Our cutting-edge services and technology, rooted in (super)acid chemistry and advanced flow technology, pave the way for unparalleled molecular diversity. This innovative approach enables direct and selective transformations that are unattainable through traditional methods. "Offering new alternatives in the service of health is essential" says Prof. Sébastien Thibaudeau, co-founder and CSO of ACTIV-H. ''Our chemical diversification offer is a new option, and our R&D program opens up concrete perspectives in this field. How We Can Support you ▶ Access to unique molecules with an alternative and powerful toolbox ▶ Explore new chemical and IP spaces ▶ A unique mode of molecular activation targeting Inert or Metabolically Sensitive Positions ▶ Revitalizing Existing Molecules by unlocking new possibilities in drug discovery Let's Collaborate Reach out today to explore possible synergies as a trusted R&D partner in Your Drug Discovery Endeavours. Request a meeting with our expert here : zahra.abada@activ-h.com. or on the CPHi event planner. #Innovation #Ingredients #drugdiscovery #APIs #Intermediates #Buildingblocks #Research #CPHIMilan

Join ACTIV-H at CPHI Milan 2024! We’re pleased to be present at the next CPHI Milan event from October 8-10, 2024! Meet Dr Zahra ABADA, our CEO, to discover how ACTIV-H unique technology and expertise can help accelerate your pipeline and propel your early drug discovery projects forward. 📅 Schedule a short meeting here : zahra.abada@activ-h.com At ACTIV-H, we specialize in delivering novel molecules and enhancing the chemical diversity for our clients. Our cutting-edge services and technology, rooted in (super)acid chemistry and advanced flow technology, pave the way for unparalleled molecular diversity. This innovative approach enables direct and selective transformations that are unattainable through traditional methods. "Offering new alternatives in the service of health is essential" says Prof. Sébastien Thibaudeau, co-founder and CSO of ACTIV-H. ''Our chemical diversification offer is a new option, and our R&D program opens up concrete perspectives in this field." What We Offer •Access to unique molecules with a complemetary and powerful toolbox •Explore new chemical and IP spaces •A unique mode of molecular activation targeting Inert or metabolically sensitive positions •Revitalizing Existing molecules by unlock new possibilities in drug discovery We look forward to meeting you in this exciting italian edition 'at the heart of Pharma’ and explore how our unique platform can benefit your projects. See you there! #CPHIMilan #PharmaEvent #Research #deeptech #Networking #Innovation #PharmaIndustry #SmallMolecules

🔔 It’s Day 2 of #EFMCISMC2024 in Rome! We are glad to be here, soaking in all the insights and innovations in medicinal chemistry. If you’re at the symposium and want to chat about the latest trends in drug discovery or explore how we can access unique small molecule, feel free to reach out here : contact@activ-h.com - let’s make the most of this amazing event together! #MedicinalChemistry #DrugDiscovery #smallmolecules #innovation

Merci à l'Université de Poitiers pour cet article mettant en lumière ACTIV-H, notre startup née des travaux de l'IC2MP !   Nous sommes fiers de contribuer à l'innovation dans le domaine pharma. Un grand merci à Romain Mudrak pour sa visite dans nos locaux et pour cette interview qui met parfaitement en lumière notre mission : ouvrir de nouvelles voies de synthèse pour la découverte de médicaments.   #Innovation #Deeptech #Molecules #drugdiscovery

Merci à l’Université de Poitiers pour cet article mettant en lumière ACTIV-H, notre startup née des travaux de l'IC2MP ! Nous sommes fiers de contribuer à l'innovation dans le domaine pharmaceutique. Un grand merci à Romain Mudrak pour sa visite dans nos locaux et pour cette interview qui capture parfaitement notre mission : ouvrir de nouvelles voies pour la découverte de médicaments. Ensemble, nous repoussons les frontières de la chimie au service de la santé! #Innovation #Deeptech #Molecules #drugdiscovery

Countdown to #EFMCISMC2024 in Rome! The EFMC - European Federation for Medicinal Chemistry and Chemical Biology is just days away on September 1-5! 📅 Get in touch with our CSO, Prof. Sébastien Thibaudeau : sebastien.thibaudeau@activ-h.com Are you tackling complex molecule synthesis in drug discovery or seeking access to a pool of small molecules inaccessible through standard chemical transformations? Let's connect and discuss how our innovative superacid-based synthesis can expand your chemical space and accelerate your research. Looking forward to exploring new frontiers in medicinal chemistry with you! #MedicinalChemistry #DrugDiscovery #smallmolecules #Partnerships

Exciting News! ACTIV-H will attend the XXVIII EFMC - European Federation for Medicinal Chemistry and Chemical Biology - International Symposium on Medicinal Chemistry (EFMC-ISMC 2024), taking place from September 1 to 5 in Rome, Italy! Our Chief Scientific Officer, Prof. Sébastien Thibaudeau will be at the event from September 2nd to 4th, and is eager to engage with fellow academics/professionals and discuss our unique technology to access a new chemical diversity. Looking forward to connecting with you all and exploring new opportunities in medicinal chemistry ! 📅 Schedule an in-dept meeting with Sébastien here : contact@activ-h.com 🌐 Explore our services here : www.activ-h.com #EFMCISMC2024 #MedicinalChemistry #ACTIVH #Innovation #MolecularTransformation #Networking #Pharmaceuticals #Drugdiscovery

Join ACTIV-H at CPHI Milan 2024! We’re pleased to be present at the next CPHI Milan event from October 8-10, 2024! Meet Dr Zahra ABADA, our CEO, to discover how ACTIV-H unique technology and expertise can help accelerate your pipeline and propel your early drug discovery projects forward. 📅 Schedule a short meeting here : zahra.abada@activ-h.com At ACTIV-H, we specialize in delivering novel molecules and enhancing the chemical diversity for our clients. Our cutting-edge services and technology, rooted in (super)acid chemistry and advanced flow technology, pave the way for unparalleled molecular diversity. This innovative approach enables direct and selective transformations that are unattainable through traditional methods. "Offering new alternatives in the service of health is essential" says Prof. Sébastien Thibaudeau, co-founder and CSO of ACTIV-H. ''Our chemical diversification offer is a new option, and our R&D program opens up concrete perspectives in this field." What We Offer •Access to unique molecules with a complemetary and powerful toolbox •Explore new chemical and IP spaces •A unique mode of molecular activation targeting Inert or metabolically sensitive positions •Revitalizing Existing molecules by unlock new possibilities in drug discovery We look forward to meeting you in this exciting italian edition 'at the heart of Pharma’ and explore how our unique platform can benefit your projects. See you there! #CPHIMilan #PharmaEvent #Research #deeptech #Networking #Innovation #PharmaIndustry #SmallMolecules